Our Mission is to develop orally active molecules against some of the most impactful targets in human disease biology.
Oral FcRn Inhibitor
Our first-in-class oral FcRn inhibitor will offer patients and physicians advantages over injectable biologics, including a potentially broad range of indication opportunities.
Our approach to FcRn inhibition leverages chemistry and technology spanning the molecular weight continuum of small molecules and peptides.
Our Team
We are curious, creative, and relentless drug-hunters, pushing the boundaries of drug discovery, to transform promising ideas into life-changing medicines.
We built our multidisciplinary team with vetted drug discovery experts that have contributed during their careers to multiple IND filings, lead optimization, and hit finding campaigns. Our team brings together a diverse array of expertise and hundreds of combined years of pharma and biotech experience, across target classes, therapeutics areas, and drug modalities.
